Literature DB >> 1760751

Stability of CD4/CD8 ratios in man: new correlation between CD4/CD8 profiles and iron overload in idiopathic haemochromatosis patients.

R Reimão1, G Porto, M de Sousa.   

Abstract

The proportions of CD4+, CD8+ cells were determined in peripheral blood samples obtained from 27 patients with idiopathic haemochromatosis and 67 healthy controls. Samples from the patients were obtained at the start of therapy and at intervals during intensive phlebotomy treatment in which 400 ml of blood are removed each week for 6 months to 2 years. Patients varied in their CD4/CD8 ratios from 0.8 to 4.2. An individual's CD4/CD8 ratio, however, remained unaffected by the repeated removal of large volumes of blood by phlebotomy confirming the existence of a homeostatic regulation of the relative numbers of the two major peripheral T cell pools in man. Follow-up of iron reentry into the transferrin pool at the end of the intensive phlebotomy treatment indicates that the relative proportion of circulating CD4/CD8 cells is critically related to the regulation of iron absorption.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760751

Source DB:  PubMed          Journal:  C R Acad Sci III        ISSN: 0764-4469


  16 in total

1.  Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1.

Authors:  M M Santos; M de Sousa; L H Rademakers; H Clevers; J J Marx; M W Schilham
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis.

Authors:  S V Ben-Arieh; B Zimerman; N I Smorodinsky; M Yaacubovicz; C Schechter; I Bacik; J Gibbs; J R Bennink; J W Yewdell; J E Coligan; H Firat; F Lemonnier; R Ehrlich
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 3.  Iron overload and immunity.

Authors:  Graça Porto; Maria De Sousa
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 4.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

5.  ER Stress and Iron Homeostasis: A New Frontier for the UPR.

Authors:  Susana J Oliveira; Maria de Sousa; Jorge P Pinto
Journal:  Biochem Res Int       Date:  2010-12-20

6.  A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload.

Authors:  Eugénia Cruz; Jorge Vieira; Susana Almeida; Rosa Lacerda; Andrea Gartner; Carla S Cardoso; Helena Alves; Graça Porto
Journal:  BMC Med Genet       Date:  2006-03-01       Impact factor: 2.103

7.  Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes.

Authors:  James C Barton; Ronald T Acton; Howard W Wiener; Rodney Cp Go
Journal:  BMC Blood Disord       Date:  2005-07-25

8.  A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis.

Authors:  Eugénia Cruz; Chris Whittington; Samuel H Krikler; Cláudia Mascarenhas; Rosa Lacerda; Jorge Vieira; Graça Porto
Journal:  BMC Med Genet       Date:  2008-11-06       Impact factor: 2.103

Review 9.  The unfolded protein response in hereditary haemochromatosis.

Authors:  S F de Almeida; M de Sousa
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

10.  Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areas.

Authors:  Mónica Costa; Eugénia Cruz; James C Barton; Ketil Thorstensen; Sandra Morais; Berta M da Silva; Jorge P Pinto; Cristina P Vieira; Jorge Vieira; Ronald T Acton; Graça Porto
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.